Ocular Therapeutix, Inc. (OCUL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Ocular Therapeutix Inc OCUL
$8.38
▼ -8.52%
($-0.78)
Open
$9.17
Prev Close
$9.16
Day Range
$8.36 – $9.25
52W Range
$6.23 – $16.44
Market Cap
$1.83B
Beta
0.91
EPS (TTM)
$-1.46
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-07-25 |
| Shares Out. | 217,690,000 |
| Website | ocutx.com/ ↗ |
| Phone | 13026744089 |
Ocular Therapeutix Inc is a publicly traded company under the ticker symbol OCUL on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for OCUL
Transcript : Ocular Therapeutix, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03
Dole Posts Downbeat Q1 Earnings, Joins Ocular Therapeutix And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Ocular Therapeutix reports inducement grants under Nasdaq listing rule 5635(c)(4)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular: SOL-1 Success Is Real, But Adoption Risks Keep Me At Hold
RBC Capital Reiterates Outperform on Ocular Therapeutix, Maintains $30 Price Target
Ocular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call Transcript